FDA-Inspected Site

Spes Medica srl

1 FDA inspection is on record for Spes Medica srl in Battipaglia, Italy.

483· Form 483 issued

Battipaglia, Italy · Last updated July 11, 2026

Overview

  • 1 FDA inspection is on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2012-10-04.

At a glance

Inspections

1

Form 483s

1

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
4 Oct 2012Not recordedWLView 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

4 Oct 2012
21 CFR 820.22

Quality audits - auditor independence

Cited by Melissa I Michurski

4 Oct 2012
21 CFR 820.30(i)

Design changes - Lack of or Inadequate Procedures

Cited by Melissa I Michurski

4 Oct 2012
21 CFR 820.70(c)

Environmental control Lack of or inadequate procedures

Cited by Melissa I Michurski

4 Oct 2012
21 CFR 820.70(g)(1)

Maintenance schedule, Lack of or inadequate schedule

Cited by Melissa I Michurski

4 Oct 2012
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Melissa I Michurski

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.181Cited across public-safe Form 483 observations1x
21 CFR 820.184Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.30(i)Cited across public-safe Form 483 observations1x
21 CFR 820.70(c)Cited across public-safe Form 483 observations1x
21 CFR 820.70(g)(1)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Spes Medica srl's 1 Form 483

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat